共 50 条
- [1] PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis KIDNEY INTERNATIONAL REPORTS, 2021, 6 (06): : 1629 - 1633
- [4] A Phase 1 first-in-human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF-06730512 in healthy participants PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (04):